Literature DB >> 7181528

Caseating regional lymphadenitis complicating BCG vaccination: a report of 6 cases.

P K Tam, A B Stroebel, H Saing, J T Lau, G B Ong.   

Abstract

Six infants had caseating regional lymphadenitis complicating BCG vaccination. There was a delayed onset and a lack of immediate vaccination complications. Three infants had frank abscesses. Additional affected nodes undetected clinically were found at operation in all cases. All lymph nodes contained tubercles, 3 showing acid-fast bacilli, 2 of which grew Mycobacterium bovis. Complete excision followed by antiuberculous chemotherapy produced satisfactory results.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7181528      PMCID: PMC1628081          DOI: 10.1136/adc.57.12.952

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  2 in total

1.  Suppurative lymphadenitis following intradermal B.C.G. vaccination of the newborn; a preliminary report.

Authors:  J GULD; K MAGNUS; K TOLDERLUND; K BIERING-SORENSEN; P Q EDWARDS
Journal:  Br Med J       Date:  1955-10-29

2.  Serologic diagnosis of bone and joint tuberculosis by an enzyme-linked immunosorbent assay.

Authors:  A B Stroebel; T M Daniel; J H Lau; J C Leong; H Richardson
Journal:  J Infect Dis       Date:  1982-08       Impact factor: 5.226

  2 in total
  4 in total

Review 1.  Bacille Calmette-Guérin lymphadenitis.

Authors:  Jafinder S Goraya; V S Virdi
Journal:  Postgrad Med J       Date:  2002-06       Impact factor: 2.401

2.  Needle aspiration for suppurative post-BCG adenitis.

Authors:  S A Banani; A Alborzi
Journal:  Arch Dis Child       Date:  1994-11       Impact factor: 3.791

3.  Caseating regional lymphadenitis complicating BCG vaccination.

Authors:  G G Close; M Omar
Journal:  Arch Dis Child       Date:  1983-11       Impact factor: 3.791

4.  Isoniazid or rifampicin versus bacillus Calmette-Guérin (BCG).

Authors:  P A Camargos; J I Martins; M T Fonseca
Journal:  Indian J Pediatr       Date:  1991 Jan-Feb       Impact factor: 1.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.